Immunoaffinity LC-MS/MS for quantitative determination of a free and total protein target as a target engagement biomarker.

about

Opportunities and challenges for hybrid immunoaffinity LC-MS approach for quantitative analysis of protein biomarkers.

P2860

Q55066440-8EF83B37-92BD-489A-8DD9-AFF70936C589

P2860

Immunoaffinity LC-MS/MS for quantitative determination of a free and total protein target as a target engagement biomarker.

Item

http://www.wikidata.org/entity/Q47601399

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@en

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@nl

type

Item

label

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@en

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@nl

prefLabel

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@en

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@nl

P1476

Immunoaffinity LC-MS/MS for qu ...... a target engagement biomarker.

@en

P2093

Eugene Ciccimaro

http://www.w3.org/2001/XMLSchema#string

Hongwei Zhang

http://www.w3.org/2001/XMLSchema#string

Huadong Sun

http://www.w3.org/2001/XMLSchema#string

Huidong Gu

http://www.w3.org/2001/XMLSchema#string

Petia Shipkova

http://www.w3.org/2001/XMLSchema#string

Qihong Zhao

http://www.w3.org/2001/XMLSchema#string

Timothy V Olah

http://www.w3.org/2001/XMLSchema#string

P2860

Translational Medicine Guide transforms drug development processes: the recent Merck experience

Target engagement in lead generation

Selecting the correct weighting factors for linear and quadratic calibration curves with least-squares regression algorithm in bioanalytical LC-MS/MS assays and impacts of using incorrect weighting factors on curve stability, data quality, and assay

Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation.

Bioanalytical approaches to quantify "total" and "free" therapeutic antibodies and their targets: technical challenges and PK/PD applications over the course of drug development.

Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.

Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.

Constitutive expression of interferon gamma-inducible protein 10 in lymphoid organs and inducible expression in T cells and thymocytes.

Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution.

P304

1573-1588

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/BIO-2017-0152

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29072496

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Immunoaffinity LC-MS/MS for quantitative determination of a free and total protein target as a target engagement biomarker.

about

P2860

P2860

Immunoaffinity LC-MS/MS for quantitative determination of a free and total protein target as a target engagement biomarker.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921